E-LIB Suche - Ergebnisse für: van Lammeren, André A. M.

1

Risk factors for graft-versus-host-disease after donor lymp..:

Koster, Eva A. S. ; von dem Borne, Peter A. ; van Balen, Peter...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

The degree of HLA matching determines the incidence of cyto..:

von dem Borne, Peter A. ; Kemps-Mols, Berit M. ; de Wreede, Liesbeth C....
Leukemia & Lymphoma. , 2024

Link: https://doi.org/10.1080/..

3

Urban greening co-creation: Participatory spatial modelling..:

Mattijssen, Thomas J.M. ; Hennen, Wil ; Buijs, Arjen E....
Urban Forestry & Urban Greening. 94 (2024) - p. 128257 , 2024

Link: https://doi.org/10.1016/..

4

Drug–drug interaction: decreased posaconazole trough concen..:

Wortman, Julia M ; Leegwater, Emiel ; Van Lammeren-Venema, Daniëlle...
Journal of Antimicrobial Chemotherapy. 78 (2023) 6 - p. 1471-1475 , 2023

Link: https://doi.org/10.1093/..

5

Feasibility, safety, and efficacy of early prophylactic don..:

van der Zouwen, Boris ; Koster, E. A. S. ; von dem Borne, P. A....
Annals of Hematology. 102 (2023) 5 - p. 1203-1213 , 2023

Link: https://doi.org/10.1007/..

6

Competitive Repopulation and Allo-Immunologic Pressure Dete..:

Koster, Eva A.S. ; von dem Borne, Peter A. ; van Balen, Peter...
Transplantation and Cellular Therapy. 29 (2023) 4 - p. 268.e1-268.e10 , 2023

Link: https://doi.org/10.1016/..

7

10-day decitabine versus 3 + 7 chemotherapy followed by all..:

Lübbert, Michael ; Wijermans, Pierre W ; Kicinski, Michal...
The Lancet Haematology. 10 (2023) 11 - p. e879-e889 , 2023

Link: https://doi.org/10.1016/..

8

Joint models quantify associations between immune cell kine..:

Koster, Eva A. S. ; Bonneville, Edouard F. ; Borne, Peter A. von dem...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Age and sex associate with outcome in older AML and high ri..:

Hilberink, Jacobien R. ; van Zeventer, Isabelle A. ; Chitu, Dana A....
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Clofarabine added to intensive treatment in adult patients ..:

Rijneveld, Anita W. ; van der Holt, Bronno ; de Weerdt, Okke...
Blood Advances. 6 (2022) 4 - p. 1115-1125 , 2022

Link: https://doi.org/10.1182/..

11

S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY ("3 +..:

Lübbert, M. ; Wijermans, P. ; Kicinski, M....
HemaSphere. 6 (2022) - p. 26-27 , 2022

Link: https://doi.org/10.1097/..

12

Addition of lenalidomide to intensive treatment in younger ..:

Löwenberg, Bob ; Pabst, Thomas ; Maertens, Johan...
Blood Advances. 5 (2021) 4 - p. 1110-1121 , 2021

Link: https://doi.org/10.1182/..

13

Spatial, infrastructural and consumer characteristics under..:

Voskamp, Ilse M. ; Visscher, Megan N. ; Vreugdenhil, Corné..
Sustainable Cities and Society. 72 (2021) - p. 102977 , 2021

Link: https://doi.org/10.1016/..

14

Habitat suitability modelling to assess the introductions o..:

Ibáñez-Justicia, Adolfo ; Alcaraz-Hernández, Juan Diego ; van Lammeren, Ron...
Parasites & Vectors. 13 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

15

Ibrutinib added to 10-day decitabine for older patients wit..:

Huls, Gerwin ; Chitu, Dana A. ; Pabst, Thomas...
Blood Advances. 4 (2020) 18 - p. 4267-4277 , 2020

Link: https://doi.org/10.1182/..